Indication for Intraoperative Volume Therapy (INDIZ IV I)
This study has been completed.
Information provided by (Responsible Party):
Professor Kai Zacharowski, M.D., Ph.D., FRCA, Johann Wolfgang Goethe University Hospitals
First received: October 14, 2011
Last updated: March 19, 2013
Last verified: March 2013
This study evaluates which substitution solutions are used in daily clincal practice in various teaching hospitals in a specific district (Frankfurt/Rhine-Main Metropolitan Region). Furthermore the indication for usage of these solutions is investigated.
Patients Undergoing Any Kind of Surgery
||Observational Model: Cohort
Time Perspective: Cross-Sectional
||Indication for Intraoperative Volume Therapy
Primary Outcome Measures:
- Number of different substitution solutions administered [ Time Frame: 24h ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Indication for substitution of the specific solution [ Time Frame: 24h ] [ Designated as safety issue: No ]
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||December 2012 (Final data collection date for primary outcome measure)
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
All patients of participating hospitals that will undergo surgery and receive intravenous fluid or volume treatment(cristalloid or colloid) will be included.
Participating hospitals are the university teaching hospitals of the Goethe University Hospital
- patients undergoing surgery receiving at least one bag of cristalloid or colloid solution
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01454258
|Goethe University Hospital
|Frankfurt am Main, Hessen, Germany, 60590 |
Johann Wolfgang Goethe University Hospitals
||Kai Zacharowski, MD, PhD
||Johann Wolfgang Goethe University Hospitals
No publications provided
ClinicalTrials.gov processed this record on May 21, 2015
||Professor Kai Zacharowski, M.D., Ph.D., FRCA, Director, Johann Wolfgang Goethe University Hospitals
History of Changes
|Other Study ID Numbers:
||INDIZ IV I
|Study First Received:
||October 14, 2011
||March 19, 2013
||Germany: Institutional Review Board